Advertisement

Gastrointestinal Bleeding

  • Sam J. Thomson
  • Matthew L. Cowan
  • Robert Morgan
  • Tony M. Rahman

Abstract

Gastrointestinal bleeding (GIB) in the critical care environment is a relatively common clinical event. The incidence of GIB is 103/100,000 cases per year in the United Kingdom (UK).1 Of these, 14% occur in patients who are already hospitalized.1 In the United States (US) the incidence of clinically significant GIB from stress-related mucosal disease (SRMD) has been estimated at 1.5%.2 GIB can be the primary reason for admission or can develop as a secondary comorbid factor in relation to the primary illness. Patients with this complication can have an increased length of stay and up to a fourfold rise in mortality.3

Keywords

Proton Pump Inhibitor Variceal Bleeding Endoscopic Therapy Argon Plasma Coagulation Proton Pump Inhibitor Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rockall TA, Logan RFA, Devlin HB et al (1995) Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ 311:222–226PubMedCrossRefGoogle Scholar
  2. 2.
    Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330:377–381PubMedCrossRefGoogle Scholar
  3. 3.
    Cook DJ, Griffith LE, Walter SD et al (2001) The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5(6):368–375PubMedCrossRefGoogle Scholar
  4. 4.
    Jain SK, Bedi APS, Suryavanshi M. Applied Anatomy and Physiology of Stomach and Duodenum. http://www.edu.rcsed.ac.uk, accessed February 29, 2008.
  5. 5.
    Calam J, Baron JH (2001) ABC of the upper GI tract: pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 323:980–982PubMedCrossRefGoogle Scholar
  6. 6.
    Allen A, Flemstrom G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288(1):C1–C19PubMedGoogle Scholar
  7. 7.
    Ritchie WP Jr (1975) Acute gastric mucosal damage induced by bile salts, acid, and ischemia. Gastroenterology 68(4 Pt 1):699–707PubMedGoogle Scholar
  8. 8.
    Kivilaakso E, Silen W (1979) Pathogenesis of experimental gastric-mucosal injury. N Engl J Med 301(7):364–369PubMedCrossRefGoogle Scholar
  9. 9.
    Mutlu GM, Mutlu EA, Factor P (2001) GI complications in patients receiving mechanical ventilation. Chest 119(4):1222–1241PubMedCrossRefGoogle Scholar
  10. 10.
    Lev R, Molot MD, McNamara J et al (1971) “Stress” ulcers following war wounds in Vietnam. A morphologic and histochemical study. Lab Invest 25(6):491–502PubMedGoogle Scholar
  11. 11.
    Hastings PR, Skillman JJ, Bushnell LS et al (1978) Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 298(19):1041–1045PubMedCrossRefGoogle Scholar
  12. 12.
    Fiddian-Green RG, McGough E, Pittenger G et al (1983) Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration. Gastroenterology 85:613–620PubMedGoogle Scholar
  13. 13.
    Patrono C, Bachmann F, Baigent C et al (2004) Expert consensus document on the use of antiplatelet agents. Eur Heart J 25(2):166–181PubMedCrossRefGoogle Scholar
  14. 14.
    Weil J, Colin-Jones D, Langman M et al (1995) Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310(6983):827–830PubMedCrossRefGoogle Scholar
  15. 15.
    Harker LA, Boisell JP, Pilgrim AJ et al (1999) Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Drug Saf 21(4):325–335PubMedCrossRefGoogle Scholar
  16. 16.
    Ng FH, Wong SY, Chang CM et al (2003) High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 18(4):443–449PubMedCrossRefGoogle Scholar
  17. 17.
    Ng FH, Wong BC, Wong SY et al (2004) Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk – a single-blind, randomized controlled study. Aliment Pharmacol Ther 19(3):359–365PubMedCrossRefGoogle Scholar
  18. 18.
    Liberopoulous EN, Elisaf MS, Tselepis AD et al (2006) Upper gastrointestinal hemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now? Platelets 17(1):1–6CrossRefGoogle Scholar
  19. 19.
    Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116(1):4–15PubMedCrossRefGoogle Scholar
  20. 20.
    Henry D, McGettigan P (2007) Selective COX-2 inhibitors: a promise unfulfilled? Gastroenterology 132(2):790–794PubMedCrossRefGoogle Scholar
  21. 21.
    Kearney PM, Baigent C, Godwin J et al (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials. BMJ 332(7553):1302–1308PubMedCrossRefGoogle Scholar
  22. 22.
    Chan FK, Wong VW, Suen BY et al (2007) Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomized trial. Lancet 369(9573):1621–1626PubMedCrossRefGoogle Scholar
  23. 23.
    Chan FK (2002) Helicobacter pylori, NSAIDs and gastrointestinal hemorrhage. Eur J Gastroenterol Hepatol 14(1):1–3PubMedCrossRefGoogle Scholar
  24. 24.
    Robertson MS, Cade JF, Clancy RL (1999) Helicobacter pylori infection in intensive care: increased prevalence and a new nosocomial infection. Crit Care Med 27(7):1276–1280PubMedCrossRefGoogle Scholar
  25. 25.
    van der Voort PH, van der Hulst RW, Zandstra DF et al (2001) Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med 27(1):68–73PubMedCrossRefGoogle Scholar
  26. 26.
    Halm U, Halm F, Thein D et al (2000) Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med 28(1):110–113PubMedCrossRefGoogle Scholar
  27. 27.
    Ong SP, Duggan A (2004) Eradication of Helicobacter pylori in clinical situations. Clin Exp Med 4(1):30–38PubMedCrossRefGoogle Scholar
  28. 28.
    Gisbert JP, Abraira V (2006) Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta analysis. Am J Gastroenterol 101(4):848–863PubMedCrossRefGoogle Scholar
  29. 29.
    Morgner A, Labenz J, Miehlke S (2006) Effective regimens for the treatment of Helicobacter pylori infection. Expert Opin Investig Drugs 15(9):991–994CrossRefGoogle Scholar
  30. 30.
    Kolbel CB, Rippel K, Klar H et al (2000) Esophageal motility disorders in critically ill patients: a 24-hour manometric study. Intensive Care Med 26(10):1421–1427PubMedCrossRefGoogle Scholar
  31. 31.
    Castell DO, Murray JA, Tutuian R et al (2004) Review article: the pathophysiology of gastro-esophageal reflux disease – esophageal manifestations. Aliment Pharmacol Ther 20(Suppl 9):14–25PubMedCrossRefGoogle Scholar
  32. 32.
    Newton M, Burnham WR, Kamm MA (2000) Morbidity, mortality, and risk factors for esophagitis in hospital inpatients. J Clin Gastroenterol 30(3):264–269PubMedCrossRefGoogle Scholar
  33. 33.
    Wessinger S, Kaplan M, Choi L et al (2006) Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal hemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23(7):937–944PubMedCrossRefGoogle Scholar
  34. 34.
    Yuan Y, Tsoi K, Hunt RH (2006) Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 119(9):719–727PubMedCrossRefGoogle Scholar
  35. 35.
    Luecke T, Pelosi P (2005) Clinical review: positive end-expiratory pressure and cardiac output. Crit Care 9(6):607–621PubMedCrossRefGoogle Scholar
  36. 36.
    Bosch J, Abraldes JG, Groszmann R (2003) Current management of portal Hypertension. J Hepatol 38(Suppl 1):S54–S68PubMedCrossRefGoogle Scholar
  37. 37.
    Koklu S, Koksal A, Yolcu OF et al (2004) Isolated splenic vein thrombosis: an unusual cause and review of the literature. Can J Gastroenterol 18(3):173–174PubMedGoogle Scholar
  38. 38.
    Schepis F, Camma C, Niceforo D et al (2001) Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 33(2):333–338PubMedCrossRefGoogle Scholar
  39. 39.
    Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann R, editors. Portal hypertension. Pathophysiology and treatment. Cambridge, MA: Blackwell; 1994. p. 72–92.Google Scholar
  40. 40.
    Carbonell N, Pauwels A, Serfaty L et al (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40(3):652–659PubMedCrossRefGoogle Scholar
  41. 41.
    de Franchis R, Primignani M (2001) Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5(3):645–663PubMedCrossRefGoogle Scholar
  42. 42.
    Ben Ari Z, Cardin F, McCormick AP et al (1999) A predictive model for failure to control bleeding during acute variceal hemorrhage. J Hepatol 31(3):443–450PubMedCrossRefGoogle Scholar
  43. 43.
    Moitinho E, Escorsell A, Bandi JC et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117(3):626–631PubMedCrossRefGoogle Scholar
  44. 44.
    Pique JM (1997) Portal hypertensive gastropathy. Baillieres Clin Gastroenterol 11(2):257–270PubMedCrossRefGoogle Scholar
  45. 45.
    Carpinelli L, Primignani M, Preatoni P et al (1997) Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol 29(6):533–540PubMedGoogle Scholar
  46. 46.
    Primignani M, Carpinelli L, Preatoni P et al (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119(1):181–187PubMedCrossRefGoogle Scholar
  47. 47.
    Burak KW, Lee SS, Beck PL (2001) Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 49(6):866–872PubMedCrossRefGoogle Scholar
  48. 48.
    Trevino HH, Brady CE 3rd, Schenker S (1996) Portal hypertensive gastropathy. Dig Dis 14(4):258–270PubMedCrossRefGoogle Scholar
  49. 49.
    Jabbari M, Cherry R, Lough JO et al (1984) Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 87(5):1165–1170PubMedGoogle Scholar
  50. 50.
    Payen JL, Cales P (1991) Gastric modifications in cirrhosis. Gastroenterol Clin Biol 15:285–295PubMedGoogle Scholar
  51. 51.
    Gostout CJ, Viggiano TR, Ahlquist DA et al (1992) The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 15(3):256–263PubMedCrossRefGoogle Scholar
  52. 52.
    Villeneuve SL, JP DMP et al (1999) Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44(5):739–742PubMedCrossRefGoogle Scholar
  53. 53.
    Schoonbroodt D, Horsmans Y, Hoang P et al (1994) Vascular gastric anomalies, CREST syndrome and primary biliary cirrhosis: efficacy of ethinyl estradiol-norethisterone combination. Gastroenterol Clin Biol 18(6–7):649–651PubMedGoogle Scholar
  54. 54.
    Henry DA, O’Connell DL (1989) Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal hemorrhage. BMJ 298(6681):1142–1146PubMedCrossRefGoogle Scholar
  55. 55.
    Sato T, Yamazaki K, Toyota J et al (2005) Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease. Hepatol Res 32(2):121–126PubMedCrossRefGoogle Scholar
  56. 56.
    Romaozinho JM, Pontes JM, Lerias M et al (2004) Dieulafoy’s lesion: management and long-term outcome. Endoscopy 36(5):416–420PubMedCrossRefGoogle Scholar
  57. 57.
    Sone Y, Kumada T, Toyoda H et al (2005) Endoscopic management and follow up of Dieulafoy lesion in the upper gastrointestinal tract. Endoscopy 37(5):449–453PubMedCrossRefGoogle Scholar
  58. 58.
    Longstreth GF (1997) Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 92(3):419–424PubMedGoogle Scholar
  59. 59.
    Peura DA, Lanza FL, Gostout CJ et al (1997) The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 92(6):924–928PubMedGoogle Scholar
  60. 60.
    Vernava AM 3rd, Moore BA, Longo WE et al (1997) Lower gastrointestinal bleeding. Dis Colon Rectum 40(7):846–858PubMedCrossRefGoogle Scholar
  61. 61.
    Yousfi M, Gostout CJ, Baron TH et al (2004) Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 99(9):1785–1789PubMedCrossRefGoogle Scholar
  62. 62.
    Hui AJ, Wong RM, Ching JY et al (2004) Risk of colonoscopic polypectomy bleeding with anticoagulants and anti-platelet agents: analysis of 1657 cases. Gastrointest Endosc59(1):44–48PubMedCrossRefGoogle Scholar
  63. 63.
    Rockall TA, Logan RF, Devlin HB et al (1996) Risk assessment after acute upper gastrointestinal hemorrhage. Gut 38(3):316–321PubMedCrossRefGoogle Scholar
  64. 64.
    Camellini L, Merighi A, Pagnini C et al (2004) Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding. Dig Liver Dis 36(4):271–277PubMedCrossRefGoogle Scholar
  65. 65.
    Blatchford O, Murray WR, Blatchford M (2000) A risk score to predict need for treatment for upper-gastrointestinal hemorrhage. Lancet 356(9238):1318–1321PubMedCrossRefGoogle Scholar
  66. 66.
    Rudolph SJ, Landsverk BK, Freeman ML (2003) Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage. Gastrointest Endosc 57(1):58–61PubMedCrossRefGoogle Scholar
  67. 67.
    Mandelstam P, Zeppa R (1983) Endotracheal intubation should precede esophagogastric balloon tamponade for control of variceal bleeding. J Clin Gastroenterol 5(6):493–494PubMedCrossRefGoogle Scholar
  68. 68.
    Grenvick A, Ayres S, Holbrook P et al (eds) (2000) Textbook of critical care, 4th edn. WB Saunders, Philadelphia, pp 40–45Google Scholar
  69. 69.
    Kwan I, Bunn F, Roberts I, WHO pre-hospital trauma care steering committee. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 2003;(3):CD002245.Google Scholar
  70. 70.
    Palmer KR, British Society of Gastroenterology Endoscopy Committee. Non variceal upper gastrointestinal hemorrhage: guidelines. Gut 2002;51(Suppl IV):iv1–iv6.Google Scholar
  71. 71.
    Hebert PC, Wells G, Blajchman MA et al (1999) A multicentre, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417PubMedCrossRefGoogle Scholar
  72. 72.
    Vlavianos P, Mac Mathuna P, Williams R et al (1999) Splanchnic and systemic haemodynamic response to Volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond) 96(5):475–481CrossRefGoogle Scholar
  73. 73.
    Abraldes JG, Dell’Era A, Bosch J (2004) Medical management of variceal bleeding in patients with cirrhosis. Can J Gastroenterol 18(2):109–113PubMedGoogle Scholar
  74. 74.
    Love DG (1999) Management of hemorrhagic events in patients receiving anticoagulant therapy. J Thromb Thrombolysis 7(2):149–152PubMedCrossRefGoogle Scholar
  75. 75.
    Baglin T (1998) Management of warfarin overdose. Blood Rev 12(2):91–98PubMedCrossRefGoogle Scholar
  76. 76.
    Marti-Carvajal AJ, Salanti G, Marti-Carvajal PI. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2007;(1):CD004887.Google Scholar
  77. 77.
    Bosch J, Thabut D, Bendsten F et al (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127(4):1123–1130PubMedCrossRefGoogle Scholar
  78. 78.
    O’Connell KA, Wood JJ, Wise RP et al (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295(3):293–298PubMedCrossRefGoogle Scholar
  79. 79.
    Hedner U (2007) Recombinant factor VIIa: it’s background, development and clinical use. Curr Opin Hematol 14(3):225–229PubMedCrossRefGoogle Scholar
  80. 80.
    Vorder Bruegge WF, Peura DA (1990) Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol 12(Suppl 2):S35–S40PubMedCrossRefGoogle Scholar
  81. 81.
    Silen W (1980) The prevention and management of stress ulcers. Hosp Pract 15(3):93–100PubMedGoogle Scholar
  82. 82.
    Cook DJ, Reeve BK, Guyatt GH et al (1996) Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 275(4):308–314PubMedCrossRefGoogle Scholar
  83. 83.
    Modlin IM, Sachs G (1998) Inhibition of the gastric acid pump. In: Modlin IM, Sachs G (eds) Acid related diseases: biology and treatment. Schnetztor-Verlag GmbH D-Konstanz, Konstanz, pp 126–145Google Scholar
  84. 84.
    Lasky MR, Metzler MH, Phillips JO (1998) A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 44(3):527–533PubMedCrossRefGoogle Scholar
  85. 85.
    Phillips JO, Metzler MH, Palmieri MT et al (1996) A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 24(11):1793–1800PubMedCrossRefGoogle Scholar
  86. 86.
    Stollman N, Metz DC (2005) Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 20(1):35–45PubMedCrossRefGoogle Scholar
  87. 87.
    Netzer P, Gaia C, Sandoz M et al (1999) Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 94(2):351–357PubMedGoogle Scholar
  88. 88.
    Brett S (2005) Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Critical Care 9(1):45–50PubMedCrossRefGoogle Scholar
  89. 89.
    Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3):858–873PubMedCrossRefGoogle Scholar
  90. 90.
    The Surviving Sepsis Campaign (SSC), an initiative of the European Society of Intensive Care Medicine, the International Sepsis Forum, and the Society of Critical Care Medicine, http://www.survivingsepsis.org, accessed February 29, 2008.
  91. 91.
    Ostro MJ, Russell JA, Soldin SJ et al (1985) Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology 89(3):532–537PubMedGoogle Scholar
  92. 92.
    Lau JY, Sung JJ, Lee KK et al (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343(5):310–316PubMedCrossRefGoogle Scholar
  93. 93.
    Lau JY, Leung WK, Wu JC et al (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356(16):1631–1640PubMedCrossRefGoogle Scholar
  94. 94.
    Leontiadis GI, Sharma VK, Howden CW (2007) Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 82(3):286–296PubMedGoogle Scholar
  95. 95.
    Cooper GS, Chak A, Way LE et al (1999) Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery and length of hospital stay. Gastrointest Endosc 49(2):145–152PubMedCrossRefGoogle Scholar
  96. 96.
    Pinkas H, McAllister E, Norman J et al (1995) Prolonged evaluation of epinephrine and normal saline solution injections in an acute ulcer model with a single bleeding artery. Gastrointest Endosc 42(1):51–55PubMedCrossRefGoogle Scholar
  97. 97.
    Cook DJ, Gayatt GH, Salena BJ et al (1992) Endoscopic therapy for acute non-variceal upper hemorrhage: a meta analysis. Gastroenterology 102(1):139–148PubMedGoogle Scholar
  98. 98.
    Chung SS, Lau JY, Sung JJ et al (1997) Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding peptic ulcers. BMJ 314(7090):1307–1311PubMedCrossRefGoogle Scholar
  99. 99.
    Marmo R, Rotondano G, Piscopo R et al (2007) Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 102(2):279–289PubMedCrossRefGoogle Scholar
  100. 100.
    Lo CC, Hsu PI, Lo GH et al (2006) Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest Endosc 63(6):767–773PubMedCrossRefGoogle Scholar
  101. 101.
    Havanond C, Havanond P. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding. Cochrane Database Syst Rev 2005;(2):CD003791.Google Scholar
  102. 102.
    Cipolletta L, Bianco MA, Rotondano G et al (2002) Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial. Gastrointest Endosc 56(4):467–471PubMedCrossRefGoogle Scholar
  103. 103.
    Lau JY, Sung JJ, Lam YH et al (1999) Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 340(10):751–756PubMedCrossRefGoogle Scholar
  104. 104.
    Mazzarolo S, Brady P (2007) Small bowel capsule endoscopy: a systematic review. South Med J 100(3):274–280PubMedCrossRefGoogle Scholar
  105. 105.
    Lefkovitz Z, Cappell MS, Lookstein R et al (2002) Radiologic diagnosis and treatment of intestinal hemorrhage and ischaemia. Med Clin North Am 86(6):1357–1399PubMedCrossRefGoogle Scholar
  106. 106.
    Whitaker SC, Gregson RH (1993) The role of angiography in the investigation of acute or chronic gastrointestinal hemorrhage. Clin Radiol 47(6):382–387PubMedCrossRefGoogle Scholar
  107. 107.
    Nicholson AA, Ettles DF, Hartley JE et al (1998) Transcatheter coil embolotherapy: a safe and effective option for major colonic hemorrhage. Gut 43(1):79–84PubMedCrossRefGoogle Scholar
  108. 108.
    Dempsey DT, Burke DR, Reilly RS et al (1990) Angiography in poor-risk patients with massive non-variceal upper gastrointestinal bleeding. Am J Surg 159(3):282–286PubMedCrossRefGoogle Scholar
  109. 109.
    Lang EV, Picus D, Marx MV et al (1992) Massive upper gastrointestinal hemorrhage with normal findings on arteriography : value of prophylactic embolization of the left gastric artery. Am J Roentgenol 158(3):547–549CrossRefGoogle Scholar
  110. 110.
    Schenker MP, Duszak R Jr, Soulen MC et al (2001) Upper gastro intestinal hemorrhage and trans catheter embolotherapy: clinical and technical factors impact in success and survival. J Vasc Interv Radiol 12(11):1263–1271PubMedCrossRefGoogle Scholar
  111. 111.
    d’Othee BJ, Surapaneni P, Rabkin D et al (2006) Microcoil embolization for acute lower gastrointestinal bleeding. Cardiovasc Intervent Radiol 29(1):49–58PubMedCrossRefGoogle Scholar
  112. 112.
    Kuo WT, Lee DE, Saad WE et al (2003) Superselective microcoil embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Intervent Radiol 14(12):1503–1509CrossRefGoogle Scholar
  113. 113.
    Bandi R, Shetty PC, Sharma RP et al (2001) Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Intervent Radiol 12(12):1399–1405CrossRefGoogle Scholar
  114. 114.
    Lang EK (1992) Transcatheter embolization in management of hemorrhage from duodenal ulcer: long-term results and complications. Radiology 182(3):703–707PubMedGoogle Scholar
  115. 115.
    Silver A, Bendick P, Wasvary H (2005) Safety and efficacy of superselective angio embolisation in control of lower gastro intestinal hemorrhage. Am J Surg 189(3):361–363PubMedCrossRefGoogle Scholar
  116. 116.
    Goulis J, Armonis A, Patch D et al (1998) Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27(5):1207–1212PubMedCrossRefGoogle Scholar
  117. 117.
    Bernard B, Cadranel JF, Valla D et al (1995) Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108(6):1828–1834PubMedCrossRefGoogle Scholar
  118. 118.
    Thalheimer U, Triantos CK, Samonakis DN et al (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54(4):556–563PubMedCrossRefGoogle Scholar
  119. 119.
    Hou MC, Lin HC, Liu TT et al (2004) Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39(3):746–753PubMedCrossRefGoogle Scholar
  120. 120.
    Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002;(2):CD002907.Google Scholar
  121. 121.
    Ioannou GN, Doust J, Rockey DC (2003) Systematic review: terlipressin in acute esophageal variceal hemorrhage. Aliment Pharmacol Ther 17(1):53–64PubMedCrossRefGoogle Scholar
  122. 122.
    Garcia-Pagan JC, Escorsell A, Moitinho E et al (1999) Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Semin Liver Dis 19(4):427–438PubMedCrossRefGoogle Scholar
  123. 123.
    Ferguson JW, Tripathi D, Hayes PC (2003) Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 18(3):253–262PubMedCrossRefGoogle Scholar
  124. 124.
    Avgerinos A, Nevens F, Raptis S et al (1997) Early administration of somatostatin and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 350(9090):1495–1499PubMedCrossRefGoogle Scholar
  125. 125.
    Patch D, Sabin CA, Goulis J et al (2002) A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 123(4):1013–1019PubMedCrossRefGoogle Scholar
  126. 126.
    Bureau C, Peron JM, Alric L et al (2002) “A La Carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 36(6):1361–1366PubMedGoogle Scholar
  127. 127.
    Helmy A, Hayes PC (2001) Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther 15(5):575–594PubMedCrossRefGoogle Scholar
  128. 128.
    The Copenhagen Esophageal Varices Sclerotherapy Project (1984) Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 311(25):1594–1600CrossRefGoogle Scholar
  129. 129.
    D’Amico G, Pietrosi G, Tarantino I et al (2003) Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 124(5):1277–1291PubMedCrossRefGoogle Scholar
  130. 130.
    Gross M, Schiemann U, Muhlhofer A et al (2001) Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 33(9):737–746PubMedCrossRefGoogle Scholar
  131. 131.
    Laine L, Cook D (1995) Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123(4):280–287PubMedCrossRefGoogle Scholar
  132. 132.
    Seewald S, Sriram PV, Naga M et al (2002) Cyanoacrylate glue in gastric variceal bleeding. Endoscopy 34(11):926–932PubMedCrossRefGoogle Scholar
  133. 133.
    Bloomfield L (1999) Working knowledge: instant glue. Sci Am 280:104CrossRefGoogle Scholar
  134. 134.
    Palejwala AA, Smart HL, Hughes M (2000) Multiple pulmonary glue emboli following gastric variceal obliteration. Endoscopy 32(1):S1–S2PubMedCrossRefGoogle Scholar
  135. 135.
    Roesch W, Rexroth G (1998) Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 30(8):S89–S90PubMedGoogle Scholar
  136. 136.
    Sengstaken RW, Blakemore AH (1950) Balloon tamponage for the control of hemorrhage from esophageal varices. Ann Surg 131(5):781–789PubMedCrossRefGoogle Scholar
  137. 137.
    Panes J, Teres J, Bosch J et al (1988) Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 33(4):454–459PubMedCrossRefGoogle Scholar
  138. 138.
    Dearden JC, Hellawell GO, Pilling J et al (2004) Does cooling Sengstaken-Blakemore tubes aid insertion? An evidence based approach. Eur J Gastroenterol Hepatol 16(11):1229–1232PubMedCrossRefGoogle Scholar
  139. 139.
    Lin TC, Bilir BM, Powis ME (2000) Endoscopic placement of Sengstaken-Blakemore tube. J Clin Gastroenterol 31(1):29–32PubMedCrossRefGoogle Scholar
  140. 140.
    Lin AC, Hsu YH, Wang TL et al (2006) Placement confirmation of Sengstaken-Blakemore tube by ultrasound. Emerg Med J 23(6):487PubMedCrossRefGoogle Scholar
  141. 141.
    Chong CF (2005) Esophageal rupture due to Sengstaken-Blakemore tube misplacement. World J Gastroenterol 11(41):6563–6565PubMedGoogle Scholar
  142. 142.
    Teres J, Cecilia A, Bordas JM et al (1978) Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 75(4):566–569PubMedGoogle Scholar
  143. 143.
    Boyer TD, Haskal ZJ (2005) American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 16(5):615–629PubMedCrossRefGoogle Scholar
  144. 144.
    Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40(4):793–801PubMedGoogle Scholar
  145. 145.
    Rössle M, Siegerstetter V, Huber M et al (1998) The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18(2):73–89PubMedGoogle Scholar
  146. 146.
    Somberg KA, Riegler JL, LaBerge JM et al (1995) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 90(4):549–555PubMedGoogle Scholar
  147. 147.
    Madoff DC, Wallace MJ, Ahrar K et al (2004) TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics 24(1):21–36PubMedCrossRefGoogle Scholar
  148. 148.
    Green BT, Rockey DC, Portwood G et al (2005) Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol 100(11):2395–2402PubMedCrossRefGoogle Scholar
  149. 149.
    Machicado GA, Jensen DM (2006) Endoscopic diagnosis and treatment of severe lower gastrointestinal bleeding. Indian J Gastroenterol 25(Suppl 1):S43–S51PubMedGoogle Scholar
  150. 150.
    Pfenninger JL (1997) Modern treatments for internal haemorrhoids. BMJ 314(7089):1211–1212PubMedCrossRefGoogle Scholar
  151. 151.
    Edelman DA, Sugawa C (2007) Lower gastrointestinal bleeding: a review. Surg Endosc 21(4):514–520PubMedCrossRefGoogle Scholar
  152. 152.
    Marohn MR, Hanly EJ, McKenna KJ et al (2005) Laparoscopic total abdominal colectomy in the acute setting. J Gastrointest Surg 9(7):881–886PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Sam J. Thomson
    • 1
  • Matthew L. Cowan
    • 1
  • Robert Morgan
    • 1
  • Tony M. Rahman
    • 2
  1. 1.Department of GastroenterologySt. George’s HospitalLondonUK
  2. 2.Departments of Intensive Care and GastroenterologySt. George’s HospitalLondonUK

Personalised recommendations